NCT06322732

Brief Summary

The purpose of this study is to identify and analyze suboptimal perinatal (obstetric-pediatric) care in the occurrence and management of severe perinatal asphyxia or death of the newborn at or near term. Perinatal asphyxia is a serious and often unexpected pathology, requiring urgent multidisciplinary care (obstetric - pediatric - intensive care, etc.) with a high level of technical expertise and care coordination. Because of its rarity and complexity, it may be subject to suboptimal care. The aim of this study is to provide feedback within the center itself, coupled in 1/3 of cases with a confidential investigation into the search for and understanding of suboptimal care. Primary endpoint: Frequency of optimal or non-optimal maternal and neonatal management of hypoxic-ischemic encephalopathy (AIE) or neonatal death related to severe perinatal asphyxia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
336

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 15, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

March 14, 2024

Last Update Submit

April 12, 2024

Conditions

Keywords

Hypoxic-ischemic encephalopathyperinatal asphyxianeonatal deathsuboptimal careconfidential inquiry

Outcome Measures

Primary Outcomes (1)

  • sub-optimal perinatal care

    Identify and analyze sub-optimal perinatal (obstetric-pediatric) care in the occurrence and management of severe perinatal asphyxia or death of the newborn at or near term.

    1 year

Secondary Outcomes (6)

  • Frequency of suboptimal care

    1 year

  • Relationship

    1 year

  • Outcome

    1 year

  • Characteristics of suboptimal care

    1 year

  • Determinantes of suboptimal care

    1 year

  • +1 more secondary outcomes

Study Arms (1)

Newborn at or near term

Newborn at or near term (≥ 36 weeks of amenorrhea), considered to be alive at the onset of labor and presenting severe perinatal asphyxia

Eligibility Criteria

AgeUp to 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Cases of severe perinatal asphyxia will be drawn from the general population of full-term or near-term deliveries in the participating network's maternity units, whether public, private or home birth, and for all types of maternity unit (type 1 - 2 or 3)

You may qualify if:

  • \- Newborn at or near term (≥ 36 weeks of amenorrhea), considered to be alive at the onset of labor and presenting severe perinatal asphyxia
  • Severe perinatal asphyxia is considered if
  • Severity in its impact on the newborn:
  • a neonatal death during the initial hospitalization, since birth and before a possible return home, before D28 ".
  • moderate to severe anoxic-ischemic encephalopathy OR
  • a newborn hospitalized in the first week of life for hypoxic-ischemic encephalopathy or convulsions related to a perpartum event.
  • AND
  • Biological perinatal asphyxia:
  • a pH (arterial or, failing that, venous) ≤ 7.10 or base deficit ≥ 16mmol/L or lactates ≥ 11mmol/L during the first three hours of life OR
  • In the absence of biological documentation of metabolic acidosis, an Apgar ≤ 5 to 5 minutes of life or the need for neonatal resuscitation (ventilatory support at birth and Apgar score ≤ 7 to 10 minutes of life).

You may not qualify if:

  • Fetal death in utero prior to hospital admission
  • Medical termination of pregnancy
  • Severe malformations with potential impact on child survival and development.
  • Neonatal encephalopathy not due to perinatal asphyxia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Guellec I, Ancel PY, Abdoul H, Garabedian C, Verspyck E, Huissoud C, Delnaud M, Graesslin B, Desplanches T, Cambonie G, Tourneux P, Debillon T, Mitha A, Loron G, Favrais G, Badr M, Chapeliere S, Brasseur-Daudruy M, Gonzalez Estevez M, Rigouzzo A, Delorme P, Kayem G. OptiNeoCare: optimisation of routine care in the management of severe perinatal asphyxia in full-term or near-term newborns - study protocol for analysis of suboptimal care by confidential inquiries and e-self report. BMJ Open. 2025 Jul 5;15(7):e106093. doi: 10.1136/bmjopen-2025-106093.

MeSH Terms

Conditions

Hypoxia-Ischemia, BrainPerinatal Death

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic Processes

Study Officials

  • Isabelle GUELLEC-RENNE, MD, PhD

    Intensive care unit - L'archet University Hospital of Nice Côte d'Azur

    STUDY DIRECTOR
  • Gilles KAYEM, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gilles KAYEM, MD, PhD

CONTACT

Charly LARRIEU, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2024

First Posted

March 21, 2024

Study Start

September 1, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

April 15, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Undecided